Literature DB >> 12752643

Interlaboratory variation in results from immunohistochemical assessment of estrogen receptor status.

Lester J Layfield, Neal Goldstein, Kathryn R Perkinson, Alan D Proia.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12752643     DOI: 10.1046/j.1524-4741.2003.09325.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  11 in total

1.  Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.

Authors:  Glenn D Francis; Margaret Dimech; Leanne Giles; Alison Hopkins
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

2.  [Interlaboratory trials for quality assurance of breast cancer biomarkers in Germany].

Authors:  C A Krusche; R von Wasielewski; J Rüschoff; A Fisseler-Eckhoff; H H Kreipe
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

3.  Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.

Authors:  Reinhard von Wasielewski; Claudia A Krusche; Joseph Rüschoff; Anette Fisseler-Eckhoff; Hans Kreipe
Journal:  Breast Care (Basel)       Date:  2008-04-15       Impact factor: 2.860

4.  Proficiency testing of immunohistochemical biomarker assays in breast cancer.

Authors:  Reinhard von Wasielewski; Svenja Hasselmann; Josef Rüschoff; Annette Fisseler-Eckhoff; Hans Kreipe
Journal:  Virchows Arch       Date:  2008-10-29       Impact factor: 4.064

Review 5.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

6.  How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction.

Authors:  Marylène Lejeune; Benoît Plancoulaine; Nicolas Elie; Ramon Bosch; Laia Fontoura; Izar de Villasante; Anna Korzyńska; Andrea Gras Navarro; Esther Sauras Colón; Carlos López
Journal:  Histochem Cell Biol       Date:  2021-08-12       Impact factor: 4.304

7.  Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.

Authors:  Anna Dvorkin-Gheva; John A Hassell
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

8.  Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.

Authors:  Balázs Győrffy; Thomas Karn; Zsófia Sztupinszki; Boglárka Weltz; Volkmar Müller; Lajos Pusztai
Journal:  Int J Cancer       Date:  2014-10-11       Impact factor: 7.396

9.  Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience.

Authors:  Jose De Jesus; Marilin Rosa
Journal:  Cancer Cell Int       Date:  2019-10-11       Impact factor: 5.722

Review 10.  Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis.

Authors:  Zsuzsanna Mihály; Balázs Győrffy
Journal:  Microarrays (Basel)       Date:  2013-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.